| Literature DB >> 22666452 |
Jacque C Young1, Brian D Dill, Chongle Pan, Robert L Hettich, Jillian F Banfield, Manesh Shah, Christophe Fremaux, Philippe Horvath, Rodolphe Barrangou, Nathan C Verberkmoes.
Abstract
The CRISPR/Cas system, comprised of clustered regularly interspaced short palindromic repeats along with their associated (Cas) proteins, protects bacteria and archaea from viral predation and invading nucleic acids. While the mechanism of action for this acquired immunity is currently under investigation, the response of Cas protein expression to phage infection has yet to be elucidated. In this study, we employed shotgun proteomics to measure the global proteome expression in a model system for studying the CRISPR/Cas response in S. thermophilus DGCC7710 infected with phage 2972. Host and viral proteins were simultaneously measured following inoculation at two different multiplicities of infection and across various time points using two-dimensional liquid chromatography tandem mass spectrometry. Thirty-seven out of forty predicted viral proteins were detected, including all proteins of the structural virome and viral effector proteins. In total, 1,013 of 2,079 predicted S. thermophilus proteins were detected, facilitating the monitoring of host protein synthesis changes in response to virus infection. Importantly, Cas proteins from all four CRISPR loci in the S. thermophilus DGCC7710 genome were detected, including loci previously thought to be inactive. Many Cas proteins were found to be constitutively expressed, but several demonstrated increased abundance following infection, including the signature Cas9 proteins from the CRISPR1 and CRISPR3 loci, which are key players in the interference phase of the CRISPR/Cas response. Altogether, these results provide novel insights into the proteomic response of S. thermophilus, specifically CRISPR-associated proteins, upon phage 2972 infection.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22666452 PMCID: PMC3364186 DOI: 10.1371/journal.pone.0038077
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Number of proteins, peptides, and spectra identified by LC-MS/MS in cellular (MOI = 0.1 and 1) or PEG-enriched viral fractions (MOI = 1) at each time point of infection.
| Sample Fraction | Time Point (hpi) | Protein Identifications(Total/Viral) | Peptide Identifications(Total/Viral) | MS/MS Spectra (Total/Viral) |
| Viral (MOI = 1) | 0 | 2/1 | 14/2 | 119/3 |
| Viral (MOI = 1) | 0.5 | 6/4 | 70/15 | 143/14 |
| Viral (MOI = 1) | 1 | 84/17 | 1170/266 | 3311/726 |
| Viral (MOI = 1) | 2 | 86/16 | 1217/299 | 3197/824 |
| Viral (MOI = 1) | 4 | 68/12 | 845/209 | 2104/544 |
| Viral (MOI = 1) | 24 | 61/14 | 611/269 | 1972/1299 |
| Cellular (MOI = 1) | 0 | 625/0 | 8151/0 | 27821/0 |
| Cellular (MOI = 1) | 0.5 | 540/18 | 6503/138 | 26438/335 |
| Cellular (MOI = 1) | 1 | 477/32 | 5046/567 | 12866/2341 |
| Cellular (MOI = 1) | 2 | 616/35 | 6662/565 | 14015/1969 |
| Cellular (MOI = 1) | 4 | 477/29 | 4314/366 | 12002/1789 |
| Cellular (MOI = 1) | 24 | 560/31 | 6599/453 | 15628/1005 |
| Cellular (MOI = 0.1) | 0 | 650/0 | 6679/0 | 27499/0 |
| Cellular (MOI = 0.1) | 0.5 | 693/7 | 6928/34 | 30023/61 |
| Cellular (MOI = 0.1) | 1 | 810/26 | 9618/198 | 35347/415 |
| Cellular (MOI = 0.1) | 2 | 611/28 | 5525/178 | 20147/521 |
| Cellular (MOI = 0.1) | 4 | 732/24 | 8217/170 | 28244/388 |
| Cellular (MOI = 0.1) | 24 | 780/27 | 10185/228 | 26908/446 |
| Cellular (Uninfected) | 0 | 697/0 | 7892/0 | 25345/0 |
| Cellular (Uninfected) | 0.5 | 670/0 | 7370/0 | 30168/0 |
| Cellular (Uninfected) | 1 | 698/0 | 8132/0 | 30637/0 |
| Cellular (Uninfected) | 2 | 717/0 | 7898/0 | 28582/0 |
| Cellular (Uninfected) | 4 | 741/0 | 8940/0 | 30421/0 |
| Cellular (Uninfected) | 24 | 706/0 | 8979/0 | 34137/0 |
Proteins, peptides, and spectral values are based on non-redundant identifications.
All numbers are averages of two technical replicate runs.
Figure 1Phage 2972 spectral abundances.
A.) Depiction of phage 2972, color coded according to functional modules. Each arrow represents an open reading frame and numbers on top are normalized spectral counts totaled across all MS runs at MOI = 1. B.) Normalized spectral counts were added together at each time point of infection for MOI = 1 (left panel) and MOI = 0.1 (right panel). Optical density measurements (600 nm) (blue line) show cell lysis occurring immediately following the time points in which the highest numbers of phage spectra are detected at each MOI. Colors within each bar correspond to phage functional modules.
Sequence coverages of phage 2972 proteins from virus-enriched and cellular fractions across infection time points.
| Module | Orf | Description, Molecular Weight | Virus Enriched Fraction MOI = 1 | Cellular FractionMOI = 1 | Cellular FractionMOI = 0.1 | |||||||||||||||
| 0 | 0.5 | 1 | 2 | 4 | 24 | 0 | 0.5 | 1 | 2 | 4 | 24 | 0 | 0.5 | 1 | 2 | 4 | 24 | |||
|
| 1 | unknown function, MW:16160 | 65% | 80% | 85% | 69% | 71% | 66% | 63% | 40% | 35% | |||||||||
|
| 2 | terminase small subunit, MW:16777 | 19% | 24% | 25% | 56% | 31% | 85% | 71% | 67% | 81% | 19% | 38% | 25% | 11% | |||||
| 3–4 | terminase large subunit, MW: 47066 | 16% | 43% | 20% | 19% | |||||||||||||||
|
| 5 | portal protein, MW:57498 | 50% | 58% | 50% | 51% | 33% | 56% | 58% | 55% | 53% | 43% | 25% | 24% | 25% | |||||
| 6 | head protein, MW:34367 | 21% | 14% | 13% | 12% | 19% | 54% | 53% | 47% | 85% | 30% | 18% | 17% | 24% | ||||||
| 7 | scaffold protein, MW:21262 | 34% | 94% | 96% | 77% | 85% | 54% | 99% | 99% | 73% | 52% | 11% | 59% | 47% | 51% | 44% | ||||
| 8 | head protein, MW:12720 | 41% | 96% | 96% | 98% | 100% | 86% | 88% | 91% | 100% | 89% | 50% | 77% | 66% | 63% | 55% | ||||
| 9 | major capsid protein, MW:37491 | 10% | 20% | 81% | 85% | 82% | 82% | 59% | 83% | 84% | 81% | 82% | 37% | 62% | 61% | 65% | 63% | |||
| 10 | unknown function, MW:5997 | 89% | 53% | |||||||||||||||||
| 11 | unknown function, MW:13021 | 31% | 61% | 50% | 47% | 54% | 37% | |||||||||||||
| 12 | unknown function, MW:11470 | 66% | 73% | 68% | 70% | 58% | 64% | 39% | 58% | 35% | 30% | 30% | 45% | |||||||
|
| 13 | unknown function, MW:12495 | 49% | 35% | 35% | |||||||||||||||
| 14 | unknown function, MW:14637 | 19% | 26% | 24% | 32% | 32% | 24% | 24% | 28% | |||||||||||
| 15 | major tail protein, MW:18525 | 26% | 84% | 90% | 86% | 86% | 64% | 88% | 86% | 88% | 86% | 53% | 66% | 60% | 65% | 64% | ||||
| 16 | unknown function, MW:13138 | 39% | 100% | 98% | 93% | 84% | 58% | 50% | 66% | 48% | 30% | |||||||||
| 17 | major tail protein, MW:12613 | 43% | 42% | 23% | 36% | |||||||||||||||
| 18 | minor tail protein, MW:153506 | 9% | 12% | 8% | 17% | 14% | 20% | 14% | 14% | 2% | 8% | 5% | 10% | |||||||
| 19 | minor tail protein, MW:57710 | 18% | 20% | 6% | 22% | 18% | 28% | 15% | 23% | 17% | 7% | 15% | ||||||||
| 20 | antireceptor, MW:177330 | 18% | 22% | 14% | 16% | 5% | 22% | 29% | 25% | 34% | 2% | 5% | 7% | 18% | ||||||
| 21 | minor tail protein, MW:74279 | 11% | 10% | 7% | 5% | 4% | 6% | 4% | ||||||||||||
| 22 | unknown function, MW:14539 | 73% | 31% | 82% | 90% | 77% | 84% | 20% | 44% | |||||||||||
| 23 | unknown function, MW:5475 | 45% | 47% | 47% | 47% | 47% | 47% | |||||||||||||
|
| 24 | unknown function, MW:12328 | 33% | 33% | 38% | 33% | 38% | 28% | 23% | |||||||||||
| 25 | holin, MW:12004 | 31% | 75% | 74% | 72% | 59% | 39% | |||||||||||||
| 26 | lysin, MW:21754 | 49% | 48% | 38% | 39% | 49% | 44% | 35% | 31% | 20% | 29% | 42% | ||||||||
|
| 30 | unknown function, MW:5249 | ||||||||||||||||||
| 31 | cro-like repressor, MW:7850 | 92% | 84% | 56% | 42% | 54% | 46% | 46% | ||||||||||||
| 32 | unknown function, MW:5039 | 85% | 58% | |||||||||||||||||
|
| 33 | unknown function, MW:18072 | 53% | 65% | 64% | 52% | 60% | 32% | 32% | 43% | 52% | |||||||||
| 34 | unknown function, MW:26164 | 28% | 21% | 47% | 46% | 66% | 36% | 22% | 35% | 44% | ||||||||||
| 35 | helicase, MW:50968 | 9% | 6% | 10% | 9% | |||||||||||||||
| 36 | unknown function, MW:17290 | 82% | 99% | 99% | 89% | 82% | 48% | 88% | 77% | 88% | 93% | |||||||||
| 37 | replication protein, MW:30474 | 29% | 15% | 28% | 33% | 16% | 16% | |||||||||||||
| 38 | primase, MW:59060 | 9% | 34% | 40% | 15% | 36% | 24% | 11% | 20% | 30% | ||||||||||
|
| 39 | unknown function, MW:12133 | ||||||||||||||||||
| 40 | unknown function, MW:9580 | 25% | 37% | 52% | 25% | |||||||||||||||
| 41 | unknown function, MW:6311 | |||||||||||||||||||
| 42 | DNA binding protein, MW:19572 | 23% | 41% | 18% | 52% | 54% | 54% | 48% | 57% | |||||||||||
| 43 | unknown function, MW:12132 | 37% | 35% | 26% | 24% | 26% | ||||||||||||||
| 44 | unknown function, MW:27652 | 47% | 86% | 83% | 45% | 72% | 31% | 52% | 56% | 41% | ||||||||||
Values are percent sequence coverages determined by dividing the number of amino acids detected in the mass spectrometry run by the total number of amino acids in a given protein. Numbers are averages between two technical replicates. Phage functional modules are labeled on the right [18]. * Orf1 is part of the transcriptional regulation module. Intron regions are not included in the figure (orf27–29) and orf 3 and orf4 encode one protein due to a splicing event [18].
Figure 2COG classification of S. thermophilus proteomes across infection time points.
Proteins were grouped into functional categories by COG assignments. Percentages were calculated using normalized spectral counts averaged between two technical replicates.
Figure 3Volcano plot of protein abundance changes during peak infection at MOI = 1.
Normalized spectral counts were averaged between two technical replicates and the log2 ratios taken between time 0 (pre-infection) and 1 hour post infection (peak infection). P-values were calculated using the exact Poisson test as described in the Materials and Methods section. The -log10 of the P-values are plotted on the y-axis. Red color indicates an increase in abundance, green a decrease in abundance, and grey, no change. Diamonds represent host proteins: 1.) glyceraldehyde -3-phosphate dehydrogenase, 2.) pyruvate kinase, 3.) 3-phosphoglycerate kinase, 4.) ribosomal protein S9, 5.) ribosomal protein S8, 6.) ATP synthase, β subunit, 7.) ABC transporter, ATPase, 8.) RNA polymerase, β-subunit. Cas proteins are highlighted in yellow: 9.) Cas6e (CRISPR4), 10.) Cas7 (CRISPR4), 11.) Cas9 (CRISPR1), and 12.) Cas9 (CRISPR3). Phage proteins are depicted in circles: 13. and 14.) head proteins, 15.) scaffold protein, 16.) tail protein, 17.) terminase small subunit, 18.) portal protein, 19.-23.) phage proteins of unknown function.
Figure 4Restriction modification protein subunits increased at peak infection times.
Bars indicate normalized spectral counts averaged between two technical replicates and lines are optical density measurements taken at each time point. Untreated cells MOI = 0, green bars and lines, infected cells at MOI = 0, maroon bars and lines, and infected cells at MOI = 1, blue bars and lines. From top left to bottom right: Type I restriction-modification system methyltransferase subunit (ST89_075300), Restriction endonuclease S subunit (ST89_099800) Restriction-modification enzyme type I S subunit; specificity determinant HsdS (ST89_187033), Restriction-modification enzyme type I M subunit; type IC modification subunit HsdM (ST89_187066).
Expression of Cas proteins from S. thermophilus DGCC710 across time.
| Protein | Description | Loci | MOI = 1 | MOI = 0.1 | MOI = 0 | |||||||||||||||
| 0 | 0.5 | 1 | 2 | 4 | 24 | 0 | 0.5 | 1 | 2 | 4 | 24 | 0 | 0.5 | 1 | 2 | 4 | 24 | |||
| ST89_070900 | Cas9 | CRISPR1 | 15 | 6 | 89 | 80 | 9 | 8 | 16 | 12 | 18 | 48 | 33 | 16 | 18 | 21 | 17 | 22 | 21 | 17 |
| ST89_071000 | Cas1 | |||||||||||||||||||
| ST89_071100 | Cas2 | |||||||||||||||||||
| ST89_071200 | Cas4 | |||||||||||||||||||
| ST89_097000 | Cas1 | CRISPR2 | 1 | |||||||||||||||||
| ST89_097100 | Cas2 | |||||||||||||||||||
| ST89_097200 | Cas6 | |||||||||||||||||||
| ST89_097300 | Cas10 | 2 | 1 | 1 | ||||||||||||||||
| ST89_097400 | Csm2 | 1 | 1 | |||||||||||||||||
| ST89_097500 | Csm3 | 4 | 3 | 3 | 2 | 4 | 2 | 2 | 1 | 4 | 2 | 4 | 2 | 4 | 4 | 4 | ||||
| ST89_097600 | Csm4 | 1 | 1 | 1 | 4 | 1 | 1 | |||||||||||||
| ST89_097700 | Csm5 | 2 | 2 | 2 | 2 | 2 | 1 | 4 | 1 | |||||||||||
| ST89_097800 | Csm6 | |||||||||||||||||||
| ST89_147700 | Cas9 | CRISPR3 | 7 | 6 | 61 | 50 | 8 | 7 | 10 | 10 | 19 | 10 | 8 | 7 | 4 | 7 | 10 | 10 | 8 | |
| ST89_147600 | Cas1 | |||||||||||||||||||
| ST89_147500 | Cas2 | |||||||||||||||||||
| ST89_147400 | Csn2 | |||||||||||||||||||
| ST89_103880 | Cas3 | CRISPR4 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | |||||||||||
| ST89_103870 | Cse1 | 1 | 1 | 1 | ||||||||||||||||
| ST89_103860 | Cse2 | 1 | 5 | 1 | 1 | 1 | 2 | 1 | 3 | 1 | 1 | 1 | ||||||||
| ST89_103850 | Cas7 | 19 | 23 | 101 | 58 | 16 | 11 | 14 | 19 | 12 | 29 | 15 | 15 | 10 | 11 | 9 | 10 | 8 | 12 | |
| ST89_103840 | Cas5 | 2 | 3 | 1 | 2 | 4 | 3 | 3 | 5 | 1 | 2 | 3 | 2 | 1 | ||||||
| ST89_103830 | Cas6e | 6 | 6 | 23 | 18 | 6 | 7 | 2 | 2 | 2 | 2 | 1 | 8 | 1 | ||||||
| ST89_103820 | Cas1 | 7 | 2 | 1 | ||||||||||||||||
| ST89_103810 | Cas2 | |||||||||||||||||||
Values are averaged normalized spectral counts taken at each time point from cells infected at MOI = 1, MOI = 0.1, and uninfected cells (MOI = 0). All Cas proteins were detected by unique peptides.
Figure 5Cas proteins changing in response to phage 2972 infection.
Values are normalized spectral counts averaged between two technical replicates. Untreated cells MOI = 0, green bars, infected cells MOI = 0, maroon bars, and infected cells at MOI = 1, blue bars. Lines of the same color represent optical density measurements for each group. From top left to bottom right: Cas9 (ST89_070900) from CRISPR1 locus, Cas9 (ST89_097000) from CRISPR3 locus, Cas6e (ST89_103830) and Cas7 (ST89_103850) from CRISPR4 locus.